Author:
Schmittel A.,Bechrakis N. E.,Foerster M. H.,Thiel E.,Keilholz U.
Publisher
Springer Science and Business Media LLC
Reference44 articles.
1. Agarwala SS, Glaspy J, O’Day SJ et al. (2001) Results from a randomized phase III study comparing combined treatment with histamine dihydrochloride plus interleukin-2 versus interleukin-2 alone in patients with metastatic melanoma. J Clin Oncol 20:125–133
2. Agarwala SS, Hauschild A, O’Day S, Whitman E, Gehlsen KR, Glaspy J, Naredi P, Hellstrand K (2004) Efficacy and safety analyses of two multicenter, randomized phase III trials of histamine dihydrochloride (Ceplene) plus interleukin-2 in patients with metastatic melanoma. Ann Oncol 15 [Suppl 3]:772
3. Agarwala SS, Panikkar R, Kirkwood JM (2004) Phase I/II randomized trial of intrahepatic arterial infusion chemotherapy with cisplatin and chemoembolization with cisplatin and polyvinyl sponge in patients with ocular melanoma metastatic to the liver. Melanoma Res 14:217–222
4. Asea A, Hermodsson S, Hellstrand K (1996) Histaminergic regulation of natural killer cell-mediated clearance of tumour cells in mice. Scand J Immunol 43:9–15
5. Becker JC, Terheyden P, Kampgen E et al. (2002) Treatment of disseminated ocular melanoma with sequential fotemustine, interferon alpha, and interleukin 2. Br J Cancer 87:840–845
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献